Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30514382 | 0.89 | TYMP (0.42) | TYMPST6GAL1 | |
| SCHEMBL6835021 | 0.89 | TYMP (0.39) | TYMPST6GAL1 | |
| SCHEMBL7079295 | 0.83 | TYMP (0.37) | TYMPST6GAL1 | |
| SCHEMBL5201335 | 0.77 | TYMP (0.42) | TYMPST6GAL1 | |
| SCHEMBL17223095 | 0.77 | TYMP (0.41) | TYMP | |
| SCHEMBL31629449 | 0.73 | PDE4D (0.41) | ST6GAL1 | |
| Benzaldehyde SCHEMBL7181882 | 0.73 | TYMP (0.44) | TYMPST6GAL1 | |
| SCHEMBL8042942 | 0.73 | ST6GAL1 (0.34) | TYMPST6GAL1 | |
| SCHEMBL5318029 | 0.73 | BACE1 (0.36) | TYMPST6GAL1 | |
| SCHEMBL16401939 | 0.72 | TYMP (0.42) | TYMP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030036649-A1 | 2' modified oligonucleotides | ISIS PHARMACEUTICALS, INC. | 2003-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030036649-A1 | 2' modified oligonucleotides | DCLRE1B, POLRMT, POLM | TYMP 10/4885ST6GAL1 1797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.